[go: up one dir, main page]

FI906213L - Oxazolderivat. - Google Patents

Oxazolderivat. Download PDF

Info

Publication number
FI906213L
FI906213L FI906213A FI906213A FI906213L FI 906213 L FI906213 L FI 906213L FI 906213 A FI906213 A FI 906213A FI 906213 A FI906213 A FI 906213A FI 906213 L FI906213 L FI 906213L
Authority
FI
Finland
Prior art keywords
oxazole derivatives
oxazole
derivatives
Prior art date
Application number
FI906213A
Other languages
English (en)
Finnish (fi)
Other versions
FI906213A0 (fi
Inventor
Nicholas Meanwell
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of FI906213A0 publication Critical patent/FI906213A0/fi
Publication of FI906213L publication Critical patent/FI906213L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI906213A 1989-12-20 1990-12-17 Oxazolderivat. FI906213L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45354889A 1989-12-20 1989-12-20
US58002190A 1990-09-10 1990-09-10

Publications (2)

Publication Number Publication Date
FI906213A0 FI906213A0 (fi) 1990-12-17
FI906213L true FI906213L (fi) 1991-06-21

Family

ID=27037150

Family Applications (1)

Application Number Title Priority Date Filing Date
FI906213A FI906213L (fi) 1989-12-20 1990-12-17 Oxazolderivat.

Country Status (12)

Country Link
EP (1) EP0434034A1 (xx)
JP (1) JPH04217966A (xx)
KR (1) KR910011810A (xx)
CN (4) CN1028173C (xx)
CA (1) CA2032674A1 (xx)
FI (1) FI906213L (xx)
HU (2) HU206100B (xx)
IL (1) IL96747A0 (xx)
NO (1) NO905444L (xx)
NZ (1) NZ236474A (xx)
PT (1) PT96276A (xx)
YU (1) YU240990A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
HUT76341A (en) * 1993-12-20 1997-08-28 Fujisawa Pharmaceutical Co Process for preparation of 4,5-diaryloxazole derivatives and pharmaceutical compositions containing them
TW401408B (en) * 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PE20060362A1 (es) * 2004-05-24 2006-05-15 Irm Llc Compuestos de oxazol como moduladores de ppar
EP1945633A1 (en) * 2005-11-07 2008-07-23 Irm Llc Compounds and compositions as ppar modulators
JP6121339B2 (ja) 2012-02-13 2017-04-26 武田薬品工業株式会社 芳香環化合物
JP6095580B2 (ja) 2012-02-13 2017-03-15 武田薬品工業株式会社 芳香環化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
US3895115A (en) * 1974-03-01 1975-07-15 Serono Ist Farm Method of inhibiting platelet aggregation
GB1507032A (en) * 1974-08-06 1978-04-12 Serono Lab 2-thiol-4,5-diphenyloxazole s-derivatives

Also Published As

Publication number Publication date
NO905444L (no) 1991-06-21
CN1028173C (zh) 1995-04-12
CN1101042A (zh) 1995-04-05
CN1101043A (zh) 1995-04-05
NZ236474A (en) 1993-07-27
CA2032674A1 (en) 1991-06-21
EP0434034A1 (en) 1991-06-26
HU206100B (en) 1992-08-28
PT96276A (pt) 1991-09-30
NO905444D0 (no) 1990-12-18
JPH04217966A (ja) 1992-08-07
HU908361D0 (en) 1991-07-29
YU240990A (sh) 1992-12-21
CN1052667A (zh) 1991-07-03
KR910011810A (ko) 1991-08-07
CN1101041A (zh) 1995-04-05
IL96747A0 (en) 1991-09-16
FI906213A0 (fi) 1990-12-17
HU9201706D0 (en) 1992-08-28
HUT59116A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
DE122004000043I1 (de) Carbostryril-Derivate.
FI901666A0 (fi) Anordning foer behandling av byggdelar med en gripanordning.
DE59008702D1 (de) Oxazol- bzw. Thiazolcarbonsäureamide.
DE69008682D1 (de) Guanidinobenzolderivate.
ATE74350T1 (de) Dehydrocholecalciferolderivate.
ATE124407T1 (de) Chromanderivate.
FI906213L (fi) Oxazolderivat.
ATE126800T1 (de) Neplanocinderivate.
ATE119146T1 (de) Substituierte bicycloheptadionderivate.
ATE116985T1 (de) Chromanderivate.
FI902336A0 (fi) Anordning foer framstaellning av en fristaoende kiselkristall.
DE69017657D1 (de) Pyridinderivate.
DE68911192D1 (de) Phosphonoalkylpurin-Derivate.
DE58903265D1 (de) Fluorcyclopropyl-derivate.
DE69014705D1 (de) Thiazol-Derivate.
DE69005904D1 (de) Phenylpyrimidonderivate.
DE59000510D1 (de) N-phenyltetrahydroindazolderivate.
DE69019217D1 (de) Perylenquinon (UCN-1028D)-Derivate.
DE59003499D1 (de) 3-Cyano-4-phenyl-pyrrol-Derivate.
DE68913856D1 (de) Cycloalkylthiazol-Derivate.
FI922788L (fi) Skopa foer graevmaskin.
FI904891L (fi) Fenylsulfonderivat.
DE69008019D1 (de) Benzothiazol-Derivate.
DE69015726D1 (de) Piperidylthiocarbapenem-Derivate.
DE59007368D1 (de) Halogenbenzolderivate.

Legal Events

Date Code Title Description
FA Application withdrawn [patent]

Owner name: BRISTOL-MYERS SQUIBB COMPANY